Astonea Labs IPO is a bookbuilding of ₹37.67 crores. The issue is entirely a fresh issue of 27.90 lakh shares.
Astonea Labs IPO bidding opened for subscription on May 27, 2025 and will close on May 29, 2025. The allotment for the Astonea Labs IPO is expected to be finalized on Friday, May 30, 2025. Astonea Labs IPO will be list on BSE SME with a tentative listing date fixed as Tuesday, June 3, 2025.
Astonea Labs IPO price band is set at ₹128 to ₹135 per share. The minimum lot size for an application is 1000. The minimum amount of investment required by retail investors is ₹1,28,000. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,35,000. The minimum lot size investment for HNI is 2 lots (2,000 shares) amounting to ₹2,70,000.
Incorporated in 2017, Astonea Labs Ltd. is involved in the contract manufacturing of pharmaceutical and cosmetic products for both domestic and international clients. The company manufactures and markets a wide range of products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, cardiac conditions, gynecological issues, infections, and more.
In addition to pharmaceuticals, Astonea Labs offers skincare, dental care, and hair care products in various forms such as gels, creams, and serums. The company also trades in packaging and raw materials used in the pharmaceutical and cosmetic industries, ensuring compliance with industry standards.
Astonea Labs markets its own brands—“Glow Up” in the skincare segment and “Regero” in the pharmaceutical category—and is planning to launch a new brand, “Avicel.” The company also engages in export activities, supplying products to international markets such as Iraq and Yemen. Through its contract manufacturing model, Astonea Labs supports a wide range of pharmaceutical and cosmetic businesses, offering tailored and cost-effective solutions.
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.